Proteases in gastrointestinal neoplastic diseasesHERSZENYI, L; PLEBANI, M; CARRARO, P et al.Clinica chimica acta. 2000, Vol 291, Num 2, pp 171-187, issn 0009-8981Conference Paper

Gastric epithelial dysplasia : how clinicopathologic background relates to managementRUGGE, M; LEANDRO, G; FARINATI, F et al.Cancer. 1995, Vol 76, Num 3, pp 376-382, issn 0008-543XArticle

Gastrin and gastric cancer. ReplyFARINATI, F; DELLA LIBERA, G; VALIANTE, F et al.European journal of gastroenterology & hepatology. 1993, Vol 5, Num 3, pp 183-184, issn 0954-691XArticle

Epithelial dysplasia in atrophic gastritis. Bioptical follow-up studyRUGGE, M; BAFFA, R; FARINATI, F et al.The Italian journal of gastroenterology. 1991, Vol 23, Num 2, pp 70-73, issn 0392-0623, 4 p.Article

Effect of chronic ethanol consumption on activation of nitrosopyrrolidine to a mutagen by rat upper alimentary tract, lung, and hepatic tissueFARINATI, F; ZONGCAN ZHOU; BELLAH, J et al.Drug metabolism and disposition. 1985, Vol 13, Num 2, pp 210-214, issn 0090-9556Article

Mutagenic activity in gastric juice and urine of subjects with chronic atrophic gastritis. gastric epithelial dysplasia and gastric cancerFARINATI, F; LIMA, V; NACCARATO, R et al.Cancer letters. 1989, Vol 48, Num 3, pp 169-175, issn 0304-3835Article

Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinomaGIANNINI, E. G; BODINI, G; BORZIO, F et al.Alimentary pharmacology & therapeutics. 2010, Vol 31, Num 4, pp 493-501, issn 0269-2813, 9 p.Article

Oxidative DNA damage accumulation in gastric carcinogenesisFARINATI, F; CARDIN, R; DEGAN, P et al.Gut. 1998, Vol 42, Num 3, pp 351-356, issn 0017-5749Article

Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material : The role of etiology, disease activity, iron, and lipid peroxidationFARINATI, F; CARDIN, R; D'ERRICO, A et al.Hepatology (Baltimore, Md.). 1996, Vol 23, Num 6, pp 1468-1475, issn 0270-9139Article

Unresectable hepatocellular carcinoma in cirrhosis : Survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolizationFARINATI, F; DE MARIA, N; MARAFIN, C et al.Digestive diseases and sciences. 1996, Vol 41, Num 12, pp 2332-2339, issn 0163-2116Article

Cysteine and serine proteases in gastric cancerPLEBANI, M; HERSZENYI, L; FARINATI, F et al.Cancer. 1995, Vol 76, Num 3, pp 367-375, issn 0008-543XArticle

Hepatocellular carcinoma in alcoholic cirrhosis : is sex hormone imbalance a pathogenetic factor ?FARINATI, F; DE MARIA, N; MARAFIN, C et al.European journal of gastroenterology & hepatology. 1995, Vol 7, Num 2, pp 145-150, issn 0954-691XArticle

Early and advanced gastric cancer in the follow-up of moderate and severe gastric dysplasia patients. A prospective studyFARINATI, F; RUGGE, M; DI MARIO, F et al.Endoscopy (Stuttgart). 1993, Vol 25, Num 4, pp 261-264, issn 0013-726XArticle

Pathology of th gastric antrum and body associated with Helicobacter pylori infection in non-ulcerous patients : is the bacterium a promoter of intestinal metaplasia ?RUGGE, M; DI MARIO, F; CASSARO, M et al.Histopathology. 1993, Vol 22, Num 1, pp 9-15, issn 0309-0167Article

Changes in parietal and mucous cell mass in the gastric mucosa of normal subjects with age : a morphometric studyFARINATI, F; FORMENTINI, S; DELLA LIBERA, G et al.Gerontology (Basel). 1993, Vol 39, Num 3, pp 146-151, issn 0304-324XArticle

The effect of full-dose famotidine therapy on mucus and pepsin concentrationsVIANELLO, F; DI MARIO, F; VIO, A et al.Current therapeutic research. 1990, Vol 48, Num 1, pp 91-95, issn 0011-393X, 5 p.Article

Gastric ulcer und stomach aging: pathophysiology and clinical implicationsFARINATI, F; CARDIN, F; DI MARIO, F et al.Gerontology (Basel). 1988, Vol 34, Num 5-6, pp 297-303, issn 0304-324XArticle

Predictors of duodenal ulcer relapse: a 12-month study in untreated patientsDI MARIO, F; BATTAGLIA, G; VIANELLO, F et al.Gastroentérologie clinique et biologique. 1985, Vol 9, Num 10, pp 750-751, issn 0399-8320Article

Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the milan criteriaCILLO, U; VITALE, A; BURRA, P et al.American journal of transplantation (Print). 2007, Vol 7, Num 4, pp 972-981, issn 1600-6135, 10 p.Article

An oncolytic adenovirus controlled by a modified telomerase promoter is attenuated in telomerase-negative cells, but shows reduced activity in cancer cellsBORTOLANZA, S; QIAN, C; KRAMER, M. G et al.Journal of molecular medicine (Berlin. Print). 2005, Vol 83, Num 9, pp 736-747, issn 0946-2716, 12 p.Article

Tamoxifen in the treatment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled trialPERRONE, F; GALLO, C; PIAI, G et al.Current pharmaceutical design. 2002, Vol 8, Num 11, pp 1013-1019, issn 1381-6128Article

The phenotype of gastric mucosa coexisting with Barrett's oesophagusRUGGE, M; RUSSO, V; BUSATTO, G et al.Journal of clinical pathology. 2001, Vol 54, Num 6, pp 456-460, issn 0021-9746Article

Hepatic and extrahepatic malignancies in primary biliary cirrhosisFLOREANI, A; BARAGIOTTA, A; BALDO, V et al.Hepatology (Baltimore, Md.). 1999, Vol 29, Num 5, pp 1425-1428, issn 0270-9139Article

Consensus statement on diet and gastric cancerBERGLUND, G; HILL, M. J; CAYGILL, C. P. J et al.European journal of cancer prevention. 1997, Vol 6, Num 4, pp 404-407, issn 0959-8278Article

Gastric antioxidant, nitrites, and mucosal lipoperoxidation in chronic gastritis and Helicobacter pylori infectionFARINATI, F; LIBERA, G. D; CARDIN, R et al.Journal of clinical gastroenterology. 1996, Vol 22, Num 4, pp 275-281, issn 0192-0790Article